BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Telix Pharmaceuticals

Telix Pharmaceuticals logo


Telix Pharmaceuticals Limited (“Telix”) is a clinical-stage biopharamaceutical company headquartered in Melbourne, Australia. Telix is developing an advanced portfolio of clinical-stage products that address significant unmet medical need in oncology, particularly renal, prostate and brain (glioblastoma) cancer. Telix’s pipeline consists of “theranostic” radiopharmaceuticals, agents that can be used both diagnostically (via PET imaging) and therapeutically to patient benefit. Telix is an unlisted public company.

Posts Mentioning This Company

15 Biopharma Research Trends to Watch in 2022

Table of contents:    mRNA vaccines and RNA therapies  Epitranscriptomics Targeting RNA with small molecules Deep learning and big data in drug discovery Neoantigens Theranostics  Exosomes Synthetic Biology 3D Bioprinting Antibiotics “anti-trend” (and hope?) Nanotechnologies in Drug Delivery Gene Editing (CRISPR-Cas9) Aging research  Microbiome  Protein Degraders   Discoveries made in …
SHARE Share in LinkedIn Share in X Share in Facebook Send by email